CAS 1286279-29-5

BMS-813160

CAS: 1286279-29-5

BMS-813160

Formula: C₂₅H₄₀N₈O₂

Purity: ≥98%

Molecular weight: 484.64

Ref: 54-BUP08645

BMS-813160

CAS: 1286279-29-5

BMS-813160 is the first dual CCR2/CCR5 antagonist to enter Clinical development for cardiovascular.

Formula: C₂₅H₄₀N₈O₂

Purity: 99.66% - 99.79%

Color and Shape: Solid

Molecular weight: 484.64

Ref: TM-T4584

BMS-813160

CAS: 1286279-29-5

N-((1R,2S,5R)-2-((S)-3-((7-(tert-Butyl)pyrazolo[1,5-a][1,3,5]triazin-4-yl)amino)-2-oxopyrrolidin-1-yl)-5-(tert-butylamino)cyclohexyl)acetamide

Formula: C₂₅H₄₀N₈O₂

Purity: 99%

Molecular weight: 484.64

Ref: IN-DG00809592

BMS 813160

CAS: 1286279-29-5

Antagonist of chemokine receptors CCR2 and CCR5

Formula: C₂₅H₄₀N₈O₂

Purity: Min. 95%

Molecular weight: 484.64 g/mol

Ref: 3D-BB164193